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Abstract 
Background. Given the well-established associations of the personality traits alexithymia, 
impulsivity and reward sensitivity with problematic use of a variety of substances including 
alcohol and cannabis, the present study sought to determine whether daily tobacco smoking is 
similarly linked to these traits. Method. Male and female adults aged 18 to 40 years were 
recruited from the local Australian community, allowing comparison of demographically 
similar samples of current daily smokers (n = 47) to never-smokers (n = 59) on the relevant 
self-report measures. Results. Multivariate analysis of covariance revealed that current 
smokers scored significantly higher than never-smokers on indices of negative mood, 
impulsiveness, and risky alcohol use, after controlling for social desirability. No significant 
group differences were found on indices of alexithymia, reward sensitivity or punishment 
sensitivity. Conclusions. Results suggest that chronic daily cigarette smoking may be an 
exception to the maladaptive behaviours associated with alexithymia, and is driven primarily 
by mood regulation and poor impulse control.  
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Cigarette smoking is the world’s leading preventable cause of death, yet 
approximately one billion individuals continue to smoke (World Health Organisation , 2016). 
In Australia, the 2013 National Drug Strategy Household Survey (Australian Institute of 
Health and Welfare [AIHW], 2014) estimated that 12.8% of Australians were current daily 
smokers. Identification of the motives for continuing to smoke despite highly publicized 
health risks is of paramount importance in addressing this major public health concern.  
One clue to the motivation for smoking can be found in consistent reports of 
heightened negative affect among chronic smokers, such that smoking may serve as a means 
of mood regulation (e.g., Lyvers, Carlopio, Bothma & Edwards, 2014; McKee et al., 2011). 
Anxiolytic and mood enhancing effects of nicotine appear to underlie the reported ability of 
smoking to alleviate aversive mood states (Dani & De Biasi, 2001; Koob, 2008; 
McGranahan, Patzlaff, Grady, Heinemann, & Booker, 2011). Such effects might be 
particularly relevant for those with high levels of alexithymia, a trait commonly associated 
with depression, anxiety and stress as well as mood regulation difficulties (Lyvers, Makin, 
Toms, Thorberg, & Samios, 2014; Thorberg et al., 2010, 2017). Alexithymia refers a 
difficulty in identifying and describing feelings and an externally oriented thinking style 
(Taylor & Bagby, 2000).  
Both alexithymia and negative moods are highly prevalent among clients undergoing 
treatment for substance disorders (Lyvers, Hinton et al., 2014; Thorberg, Young, Sullivan & 
Lyvers, 2009). In non-clinical Australian samples, alexithymia is associated with heavier use 
of drugs such as alcohol (Lyvers, Onuoha, Thorberg & Samios, 2012), cannabis (Lyvers, 
Jamieson, & Thorberg, 2013), and caffeine (Lyvers, Duric & Thorberg, 2014). Further, social 
drinkers with higher levels of alexithymia are more likely to report drinking alcohol to cope 
with negative moods (Bruce, Curren, & Williams, 2012; Lyvers, Hasking, Albrecht, & 
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Thorberg, 2012; Thorberg et al., 2009). However, alexithymia has seldom been investigated 
in relation to cigarette smoking (e.g., Lumley, Downey, Stettner, Wehmer & Pomerleau,  
1994), and their relationship, if any, is unclear (Carton, Bayard, Jouanne & Lagrue, 2008). 
  Dawe, Gullo and Loxton (2004) described two distinct forms of impulsivity - reward 
sensitivity and rash impulsiveness – and suggested that the former promotes initiation of 
substance use, whereas the latter promotes maintenance of use in addiction. This paradigm 
has been recently supported in relation to alcohol and illicit substance use in both clinical 
(Lyvers, Hinton et al., 2014) and non-clinical Australian samples (Lyvers, Duff, Basch & 
Edwards, 2012). Reward sensitivity is presumed to reflect the functioning of the 
dopaminergic Behavioral Activation System in Gray’s (1987) theory of motivation, and 
according to Dawe et al. can be indexed by the Sensitivity to Reward (SR) scale of the 
Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ; Torrubia, Ávila, 
Moltó & Caseras, 2001). Rash impulsiveness, on the other hand, reflects executive 
dysfunction and can be measured by the Barratt Impulsiveness Scale (BIS-11; Patton, 
Stanford & Barratt, 1995). These two questionnaires were thus administered in the present 
investigation of traits linked to smoking.  
In contrast to SR, the other brain motivational system proposed by Gray (1987) – the 
Behavioral Inhibition System – is proposed to underlie punishment sensitivity, a trait that can 
be measured by the Sensitivity to Punishment (SP) scale of the SPSRQ. Unlike SR, SP has 
not been linked in any consistent way to substance use. High SP has sometimes been reported 
in problematic drinkers (Loxton & Dawe, 2001), but strong negative relationships of SP with 
cannabis use (Lyvers, Jamieson et al., 2013) and caffeine use (Lyvers, Duric et al., 2014) 
have also been observed. SP has thus been characterized as both a risk factor and a protective 
factor in relation to substance use. Given the highly publicized health hazards of cigarette 
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smoking, SP might even be expected to protect against initiation of this particular form of 
substance use.  
Smoking is often comorbid with other problematic substance use, notably alcohol 
 dependence (Trull, Waudby, & Sher, 2004), which is strongly associated with alexithymia 
(Thorberg et al., 2009).  This raises the question of whether alexithymia is associated with 
smoking as it is with problematic use of alcohol and other substances. The minimal research 
conducted to date on the possible association of smoking with alexithymia has yielded mixed 
findings. Lumley et al. (1994) found no relationship between alexithymia and nicotine 
dependence, concluding that alexithymia is unrelated to smoking and that the affect 
regulation deficits in alexithymia do not predispose to use of nicotine for mood regulation. 
However, Carton et al.(2008) cited research from France (Corcos, Flament, & Jeammet, 
2003), Finland (Kauhanen, 1993) and Poland (Grabowska, Targowski, Rozynska, 
Mierzejewska, & From, 2005) that had indicated higher levels of alexithymia or one or more 
of its dimensions (difficulty identifying feelings, difficulty describing feelings, externally 
oriented thinking) in smokers compared to non-smokers. The diverse cultural milieu of the 
above studies may complicate interpretation and comparison of their findings. More recently 
Sutherland, Carroll, Salmeron, Ross, and Stein (2013) reported that nicotine-deprived 
smokers with higher levels of alexithymia reported stronger craving for cigarettes, similar to 
the association of higher alexithymia with stronger alcohol craving reported in other work 
(Thorberg et al., 2011); however, smokers and non-smokers did not appear to differ on this 
trait in their brain imaging study. 
The present study recruited a group of current daily smokers who reported having 
smoked more than 10 cigarettes every day for at least one year, and a comparison group who 
reported that they had never tried smoking (i.e., never-smokers). Current smokers and never-
smokers were then compared on measures of alexithymia, impulsivity, negative mood, and 
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reward sensitivity – traits linked to problematic substance use in previous research – as well 
as alcohol intake given the common association of smoking with alcohol consumption. Based 
on previous research on traits associated with problematic substance use, these variables were 
all expected to be elevated in smokers compared to never-smokers. SP was measured as well; 
however, given the mixed findings of previous research on the association of SP with 
substance use, no prediction was made for this trait variable. 
Method 
Participants 
 The initial sample consisted of 112 Australian community volunteers who were 
recruited online via Qualtrics.com. This sample was subsequently reduced to 107 participants 
after deletion of multivariate outliers. One light smoker was also excluded to ensure that all 
smokers scored greater than 2 on the FTND, thus likely reflecting dependence (N = 106). 
Participants in the final sample had an age range of 18 to 40 years (M = 31.42 years, SD = 
6.30), and there were 61 females (58%) and 45 males (42%). To be included, participants 
were required to be between 18 and 40 years of age to reduce potential cohort effects (AIHW, 
2014). To participate, current smokers had to have been smoking more than 10 cigarettes per 
day for a minimum of one year to increase the likelihood that the sample reflected nicotine 
dependence. Participants were excluded if they were currently taking neurological or 
psychiatric medications, or had suffered a previous traumatic brain injury, in order to 
minimize the potential influence of such neurobiological influences on responses. 
Demographic information for the current sample is displayed in Table 1, including relevant 
information regarding the smoker group. There were no significant differences between 
smoker and never-smoker groups on age, gender, ethnicity, education level or employment. 
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Materials 
 Demographics. In the initial section of the online questionnaire, several 
demographics questions were presented. Participants specified their age and ethnicity with 
open responses. Closed questions were used to identify participants’ gender, highest level of 
education, current occupational status, and smoking status. In the instance that the participant 
was a smoker, they were posed additional questions, specifically the average quantity of 
cigarettes smoked daily, the duration of their smoking habit in years, and their rationale for 
smoking. To ensure daily smoking, participants also indicated whether they smoked every 
day or occasionally. Finally, participants indicated if they were currently taking medication 
for a psychiatric or neurological condition, and if they had ever suffered a serious head 
injury, to which dichotomous “Yes-No” responses were provided; these reflected exclusion 
criteria. 
Toronto Alexithymia Scale-20 (TAS-20; Bagby, Parker et al., 1994). This 20-item 
self-report questionnaire assesses the key facets of alexithymia: difficulty identifying feelings 
(DIF; e.g., “I am often confused about what emotion I am feeling”), difficulty describing 
feelings (DDF; e.g., “I find it hard to describe how I feel about people”), and externally-
oriented thinking (EOT; e.g., “I prefer talking to people about their daily activities rather than 
their feelings”). Participants rate their agreement with each statement on a five-point Likert 
scale, ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). The sum of responses on 
items provides subscale scores and a total score, where scores greater than 61 indicate high 
alexithymia, scores between 51 and 60 indicate borderline alexithymia, and scores less than 
51 indicate low or no alexithymia. Scores may range from 20 to 100. The Cronbach’s alpha 
reliability coefficient of the TAS-20 in the current study was .86.  
Depression Anxiety Stress Scales-21 (DASS-21; Lovibond & Lovibond, 1995). The 
DASS-21 is a 21-item measure of negative emotional states experienced over the previous 
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week. It measures three dimensions with seven items each: depression (e.g., “I felt down-
hearted and blue”), anxiety (e.g., “I felt I was close to panic”), and stress (e.g., “I found it 
hard to wind down”). Participants indicate their endorsement of the statements on a four-
point Likert scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much, 
or most of the time). Total scores for each dimension are computed by adding appropriate 
items to determine one’s experience of negative emotional states, where higher scores on 
each domain indicate higher levels of depression, anxiety or stress. The present study used 
the total score as an index of negative mood, yielding a Cronbach’s alpha coefficient of .95. 
Barratt Impulsiveness Scale (BIS-11; Patton et al., 1995). The BIS-11 is a 30-item 
self-report measure of rash impulsiveness. It assesses three domains: attentional, motor, and 
non-planning impulsiveness. BIS-11 includes items such as “I plan tasks carefully” (reverse 
scored item), where participants rate their agreement with statements on a four-point Likert 
scale ranging from 1 (Rarely/Never) to 4 (Almost Always/Always). Item responses are added 
to obtain a total score, where higher scores suggest higher levels of rash impulsiveness. In the 
current study, the BIS-11 displayed a Cronbach’s alpha coefficient of .83. 
Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ; 
Torrubia et al., 2001). The SPSRQ is a 48-item self-report measure comprised of two scales, 
sensitivity to reward (SR) and sensitivity to punishment (SP), which index the proposed 
influences of the BAS and BIS motivational systems (Gray, 1987), respectively. The SR 
(e.g., “Do you often do things to be praised?”) and SP (e.g., “Are you often afraid of new or 
unexpected situations?”) scales consist of 24 items each, where participants provide 
dichotomous responses of 1 (Yes) or 0 (No). Affirmative responses are summed to obtain 
total SR and SP scores, where higher scores indicate higher sensitivity to the respective 
domain. The Cronbach’s alpha coefficients in the current study were .87 and .81 for SP and 
SR, respectively. 
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Fagerström Test for Nicotine Dependence (FTND; Fagerström, 1978; Heatherton, 
Kozlowski, Frecker, & Fagerström, 1991). The FTND is a 6-item self-report test of nicotine 
dependence in smokers. It includes questions such as “How soon after you wake up do you 
smoke your first cigarette?”, where participants select responses that best describe their 
smoking behaviors. Item 1 is scored on a four-point scale, ranging from 0 (After 60 Minutes) 
to 3 (Within 5 minutes), as is Item 4, which ranges from 0 (10 or less) to 3 (31 or more). Item 
3 requires a dichotomous response of 0 (All others) or 1 (The first one in the morning). Items 
2, 5 and 6 also require a dichotomous response of 0 (No) or 1 (Yes). Scores on the FTND may 
range between 0 and 10, where a score less than 4 suggests low dependence, a score between 
4 and 6 suggests moderate dependence, and a score greater than 7 suggests high dependence. 
The Cronbach’s alpha coefficient for the current study was .79. 
Alcohol Use Disorders Identification Test (AUDIT; Saunders, Aasland, Babor, de 
la Fuente, & Grant, 1993). The AUDIT is a 10-item measure that assesses alcohol use (items 
1 to 3), drinking behaviors and dependence (items 4 to 6), and problems related to drinking 
(items 7 to 10) on various Likert scales. Item 1 is scored on a five-point scale ranging from 0 
(Never) to 4 (4 or more times a week), as is Item 2, which ranges from 0 (1 or 2) to 4 (10 or 
more). Items 3 to 8 are also scored on a five-point scale, ranging from 0 (Never) to 4 (Daily 
or almost daily). Items 9 and 10 are scored on a three-point scale including possible scores of 
0 (No), 2 (Yes, but not in the last year), and 4 (Yes, during the last year). Total scores are 
calculated by summing responses and may range between 0 and 40, where scores of 0 to 7 
indicate low risk drinking, 8 to 15 indicate hazardous drinking, and 16 and higher indicate 
harmful drinking. The Cronbach’s alpha coefficient for the current study was .91.  
Marlowe-Crowne Social Desirability Scale Short Form C (MC-SDS; Crowne & 
Marlowe, 1960; Reynolds, 1982). This is a 13-item scale that designed to assess the tendency 
to respond in a manner that will be perceived favourably by others. It contains items such as 
                                                                                             Alexithymia and smoking  10 
“I’m always willing to admit it when I make a mistake,” where participants respond in a 
True/False format. The number of “False” responses is summed, such that a higher number of 
“False” responses suggests higher social desirability bias in responding. The MC-SDS was 
used to control for such bias in the present study (especially given the socially undesirable 
nature of smoking in the present Australian context) and yielded a Cronbach’s alpha 
coefficient of .69. 
Procedure 
 Approval was obtained from the university ethics committee prior to data collection. 
Participants were recruited via the Qualtrics Online Sample, and were screened according to 
the inclusion and exclusion criteria. The questionnaires were presented electronically on 
Qualtrics, a survey hosting website. Participants were presented with an explanatory 
statement describing the research as an investigation of how personality traits in the 
community are related to alcohol consumption and smoking. The statement indicated that the 
questionnaire would take approximately 30 minutes to complete. Participants were informed 
that participation was voluntary, that they could withdraw at any point without penalty, and 
that their responses would not be identifiable. Participants then had to tick “I agree” to a 
statement of consent (“I acknowledge that I have read and agree with the explanatory 
statement, and consent to take part in this research”) before they could proceed further. 
Participants then proceeded through the online questionnaire, providing demographic 
information and selecting responses on Likert scales for the measures of personality and 
substance use. All measures following the demographic questions (e.g., TAS-20, BIS-11, 
SPSRQ, etc.) were separated into blocks and randomised to minimize order and fatigue 
effects. The titles of each measure were omitted to minimize response bias. Following the 
completion of the battery, Qualtrics provided participants with a monetary incentive of $1.25 
AUD.  
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Results 
Data Diagnostics 
 Analyses were conducted with SPSS Version 23.0. There were no missing cases. 
After a square root transformation was applied to AUDIT scores due to positive skew, 
skewness and kurtosis were non-significant at p < .001 for all variables, fulfilling Kim’s 
(2013) criteria for a medium-sized sample. Disregarding correlations amongst subscale and 
total scale scores for the same measure, no correlations exceeded .80, satisfying the 
assumptions of multicollinearity and singularity (Field, 2013). Box’s M was non-significant 
(p = .223), satisfying the assumption of homogeneity of covariance (Tabachnick & Fidell, 
2014). Power analyses as per G*Power conventions (Faul, Erdfelder, Buchner, & Lang, 
2009) indicated sufficient power and sample size for the present study. As mentioned earlier 
above, there were no group differences between smokers and never-smokers on any 
demographic variable, and no such differences approached significance. However, smokers 
were significantly more likely to have ever used illicit drugs than never-smokers were (χ2(1) 
= 7.91, p = .005).  
Intercorrelations  
Pearson’s bivariate correlations were conducted to assess relationships between 
continuous variables (see Table 2). In line with previous work, TAS-20 scores displayed 
significant positive correlations with scores on total BIS-11, SR, SP, and all three DASS-21 
negative mood scales. The TAS-20 displayed no relationship with FTND nicotine 
dependence scores in smokers, however AUDIT scores were positively correlated with 
FTND scores, as were all three DASS-21 scales – Depression, Anxiety and Stress. Total BIS-
11 scores were positively related to the DASS-21 scales, AUDIT and FTND. Scores on the 
MC-SDS displayed significant correlations with most variables, justifying its inclusion as a 
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covariate. Age did not significantly correlate with any variables with the exception of a 
negative correlation with the EOT subscale of the TAS-20 (see Table 2).  
Group Comparisons 
A 2 × 2 between-subjects multivariate analysis of covariance (MANCOVA) was 
conducted to assess the effect of smoking status and gender on TAS-20, BIS-11, SR, SP, 
DASS-21 subscales (Depression, Anxiety, Stress), and AUDIT scores. Due to its strong 
relationship with most variables of interest as identified by Pearson’s correlations, scores on 
the MC-SDS were input as a covariate to control for social desirability bias. Levene’s test 
indicated no violations of homogeneity of variance. As the assumption of normality was met 
in data diagnostics, Wilk’s Lambda is reported for multivariate results (Field, 2013). 
The MC-SDS index of social desirability had a significant overall multivariate effect 
(F(8, 94) = 5.31, p < .001, ῆ2 = .31, power = 1.00) as well as significant univariate effects on 
all variables except AUDIT, justifying inclusion of MC-SDS as a covariate. There was a 
significant multivariate effect of smoking status (F(8, 94) = 4.57, p < .001, ῆ2 = .28, power = 
1.00) on the dependent variables after controlling for social desirability. There were no 
significant multivariate effects for gender (F(8, 94) = 1.94, p = .063) or the smoking status by 
gender interaction (F(8, 94) = 1.09, p = .377).  
Means and standard deviations for smokers and never-smokers on each dependent 
variable are presented in Table 3. Current smokers scored higher than never-smokers on each 
of the DASS-21 subscales, Depression (F(1, 101) = 10.16, p = .002, ῆ2 = .09, power = .88), 
Anxiety (F(1, 101) = 15.56, p < .001, ῆ2 = .13, power = .97), and Stress (F(1, 101) = 8.41, p 
= .005, ῆ2 = .08, power = .82), as well as on the BIS-11 (F(1, 101) = 6.19, p = .014, ῆ2 = .06, 
power = .69), and AUDIT (F(1, 101) = 26.80, p < .001, ῆ2 = .21, power = 1.00). There was 
no significant difference between groups on TAS-20 (F(1, 101) = 0.05, p = .824), SR (F(1, 
101) = 0.76, p = .384), or SP scores (F(1, 101) = 0.36, p = .552).  
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Discussion 
The current study sought to determine whether traits associated with risky or 
problematic substance use in previous research, including alexithymia, impulsivity and 
reward sensitivity, would be similarly associated with chronic daily cigarette smoking. 
Although the limited research to date has yielded conflicting findings on alexithymia in 
relation to smoking or nicotine dependence (Carton et al., 2008; Lumley et al., 1994; 
Sutherland et al., 2013), in the present study TAS-20 alexithymia scores were predicted to be 
higher in smokers than in non-smokers based on three considerations: (1) the high levels of 
negative affect and the difficulties with mood regulation associated with alexithymia (Bruce 
et al., 2012; Lyvers, Makin et al., 2014; Thorberg et al., 2010, 2017); (2) the evidence that 
mood regulation is an important motive for smoking (Lyvers, Carlopio et al., 2014; McKee et 
al., 2011); and (3) reports that alexithymia is associated with use of other substances to 
regulate mood (Thorberg et al., 2009). However, despite the reasonable expectation that 
chronic daily smokers would show higher alexithymia scores than a sample of never-smokers 
very similar to the smoker sample in age, gender composition, education levels and 
employment status, there was no difference in alexithymia scores between the two groups. 
The present findings are all the more striking given that the very large difference between the 
current smoker sample and the never-smoker sample on the AUDIT index of alcohol 
consumption (see Table 3) was not accompanied by a significant difference on TAS-20 
despite the consistently reported positive association of alexithymia with heavier drinking in 
both clinical and non-clinical Australian samples (Lyvers, Hinton et al.,, 2014; Lyvers, 
Onuoha et al., 2012; Thorberg et al., 2010, 2017). 
Despite previous evidence of higher reward sensitivity (SR) scores in substance 
dependent inpatients compared to controls (Lyvers, Hinton et al., 2014), and reports of 
positive relationships between SR and higher levels of substance use in non-clinical samples 
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(Dawe et al., 2004; Lyvers et al., 2009), SR scores were unrelated to smoking in the present 
study. Smokers did however score significantly higher on the BIS-11 index of rash 
impulsiveness than never-smokers in the present study, and also scored significantly higher 
than never-smokers on all three DASS-21 negative mood scales – Depression, Anxiety and 
Stress. Present findings thus point to both executive and hedonic dysfunction in chronic daily 
smokers. High rash impulsiveness as indexed by BIS-11 has been linked to a heightened 
vulnerability to nicotine dependence (Doran, McChargue & Cohen, 2007; Doran, Spring & 
McChargue, 2007) as well as stronger craving and negative affect during nicotine withdrawal 
(VanderVeen, Cohen, Cukrowicz, & Trotter, 2008). Executive dysfunction as manifested by 
higher levels of rash impulsiveness in smokers is likely to interfere with smoking cessation 
attempts due to the prioritizing of immediate rewards over long-term goals (Bickel & Yi, 
2008), perhaps eventuating in “hardening” of the current population of smokers in terms of 
smoking-related psychopathology. The “hardening hypothesis” suggests that, given the 
strong social pressures against smoking in many Western countries today (including 
Australia), psychopathologies that work against quit efforts gradually become more common 
in the remaining smoking population as other smokers are able to quit (Warner & Burns, 
2003). Present results are also consistent with Dawe et al.’s (2004) notion that rash 
impulsiveness as indexed by BIS-11 is the form of impulsivity that maintains drug-taking in 
addiction, as opposed to the other form of impulsivity, SR, which promotes drug 
experimentation. 
Koob’s (2008) conceptualization of drug addictions as “hedonic homeostatic 
dysregulation” may be particularly relevant to understanding the persistence of daily smoking 
despite smokers’ awareness of the associated health risks. The heightened negative mood 
states reported by current smokers may, at least in part, reflect subjective manifestations of 
multiple daily experiences of nicotine withdrawal, which involves HPA axis dysregulation 
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(Childs & De Wit, 2009; McKee et al., 2011) and associated anxiety and irritability (Parrott, 
1999, 2004). Thus, chronic smoking may be maintained primarily to alleviate aversive 
withdrawal-induced states (Dawe & Loxton, 2004; Koob & Kreek, 2007; Parrott & Kaye, 
1999). Cigarettes replenish nicotine levels and provide short-term alleviation of withdrawal-
related negative affect, such that the negative reinforcement offered by cigarettes may drive 
persistent smoking irrespective of its maladaptive nature (Koob & Le Moal, 2001). 
Consistent with this notion, smokers in the present study most commonly cited calming and  
relief from craving as their reasons for smoking.  
The present study did not predict an association between smoking and punishment 
sensitivity as indexed by SP scores given the conflicting findings of research on other forms 
of substance use in relation to this trait. In the present study SP was not related to smoker 
status, nicotine dependence level in smokers as measured by the FTND, or alcohol 
consumption as measured by the AUDIT, despite positive correlations of SP with all three 
scales of the DASS-21 negative mood index – Depression, Anxiety and Stress – which were 
positively correlated with FTND scores. The lack of a relationship of smoking with the SP 
trait despite significant relationships of smoking with negative moods in the present sample is 
further consistent with the notion that chronic daily smoking itself promotes negative moods, 
which can then be relieved by smoking, as discussed above. Finally, the commonly reported 
association of smoking with heavier alcohol consumption (Trull et al., 2004) was reflected in 
the present study by the dramatically higher AUDIT scores of smokers compared to never-
smokers and the strong positive correlation between AUDIT and FTND scores.  
 Although the present study replicated some previously reported relationships among 
the key variables of interest, a notable limitation concerns the fact that participants were 
recruited online, hence the findings might be generalizable only to those who spend a 
relatively high proportion of their time on the internet. In any case the current findings 
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provide initial evidence of a disparity between cigarette smoking and use of other substances 
in terms of a relationship with alexithymia, even though smoking, like other forms of risky or 
problematic substance use, was associated with higher levels of rash impulsiveness and 
negative mood. The intriguing results of the present study invite speculation and further 
research as to why alexithymia is associated with use of various mood-altering substances, 
but not cigarettes, despite evidence that smokers commonly smoke to obtain relief from 
negative mood states such as depression, anxiety and stress – states commonly associated 
with alexithymia. 
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Table 1 
Demographic Characteristics of the Current Sample (N = 106) 
 Frequency  Percentage (%) 
   
Gender   
Female 61 58 
Male 45 42 
Employment Status   
Full-time 47 44 
Part-time/Casual 19 18 
Self-employed 5 5 
Unemployed 25 24 
Student 10 9 
Highest Level of Education   
Before Grade 12 8 8 
Grade 12 (High School) 13 12 
Undergraduate/TAFE 67 63 
Postgraduate 18 17 
Ethnicity   
Caucasian/White 76 72 
Asian 19 18 
European 5 5 
Aboriginal 1 1 
Not specified 5 5 
Smoking Status   
Current smoker 47 44 
Never smoked 59 56 
 
Smokers (N = 47)  
 
Number of daily cigarettes   
11-20 32 68 
21-30 12 26 
31-40 4 9 
Duration of smoking habit   
1-5 years 9 19 
Over five years 38 81 
Reasons for smoking   
Pleasure 8 17 
Calmness 20 43 
Promotes concentration 2 4 
Relieves craving 14 30 
Other 3 6 
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Table 2 
Pearson’s Bivariate Correlations between Key Study Variables 
 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1. Age ―                  
2. Total TAS -.18 ―                 
3. DIF -.16 .88** ―                
4. DDF -.08 .84** .61** ―               
5. EOT -.21* .77** .48** .55** ―              
6. Total BIS -.08 .33** .41** .20* .17 ―             
7. Attention  -.13 .54** .54** .44** .32** .79** ―            
8. Motor .02 .06 .17 -.03 -.06 .76** .42** ―           
9. Non-planning -.10 .24* .29** .10 .17 .80** .50** .34** ―          
10. SP -.14 .50** .50** .48** .22* .21* .36** -.02 .19 ―         
11. SR -.01 .23* .24* .16 .16 .21* .19 .30** .02 .15 ―        
12. Total DASS -.07 .57** .63** .43** .29** .39** .51** .18 .26** .42** .21* ―       
13. Depression -.10 .54** .61** .43** .23** .36** .50** .13 .26** .45** .16 .95** ―      
14. Anxiety -.06 .43** .52** .21* .27** .38** .41** .26** .25** .24* .25** .88** .75** ―     
15. Stress -.04 .59** .60** .52** .31** .33** .51** .11 .22* .45** .18 .94** .86** .73** ―    
16. FTND -.06 .01 .05 -.04 -.02 .24* .08 .23* .24* -.10 .07 .28** .24* .33** .22* ―   
17. AUDIT -.11 .19* .13 .18 .19* .46** .33** .43** .31** -.04 .28** .38** .35** .41** .31** .48** ―  
18. MC-SDS .08 -.43** -.40** -.34** -.34** -.24* -.39** .01 -.22* -.28** -.38** -.31** -.31** -.22* -.34** .01 -.04 ― 
Note. N = 106. *p < .05, **p < .01.
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Table 3 
Means (M) and Standard Deviations (SD) of Dependent Variables for Current Smokers and 
Never-Smokers 
Variable 
Current Smokers  
(n = 47) 
 Never-Smokers  
(n = 59) 
M (SD)  M (SD) 
Alexithymia (TAS-20) 
Impulsiveness (BIS-11) 
Depression (DASS-21) 
Anxiety (DASS-21) 
Stress (DASS-21) 
Reward Sensitivity (SR) 
Punishment Sensitivity (SP) 
Alcohol Use (AUDIT) 
53.79 (11.81) 
67.64 (11.47) 
15.51 (4.89) 
14.19 (4.48) 
15.79 (4.95) 
9.74 (4.36) 
12.98 (5.55) 
11.98 (9.00) 
 
* 
** 
*** 
** 
 
 
*** 
53.32 (11.84) 
62.80 (9.48) 
12.97 (5.10) 
11.46 (3.84) 
13.64 (4.78) 
8.97 (5.17) 
14.03 (6.17) 
3.95 (4.66) 
Note. N = 106. *p < .05, **p < .01, ***p <.001. 
 
 
